Information on minimum and maximum effective doses has great clinical utility, and new findings provide guidance.
How have the pharmaceutical industry and academic guild interests shaped the evolution of psychiatry? Lisa Cosgrove, PhD, has something to say about it.
Pseudopatients and their discontents: an historical perspective.
When we meet a new patient who presents with "classic" symptoms, there are challenges described in this brief video.
What can psychiatrists in the US do to better prepare themselves and their patients for potential natural disasters? Dr Armen Goenjian, research psychiatrist at the David Geffen School of Medicine at University of California, Los Angeles, answers that question and more in this Psychiatric Times exclusive.
After receiving complaints, the FDA’s Office of Prescription Drug Promotion rebukes the pharmaceutical company for misleading advertising.
Chronotherapy presents a unique tool to add to the armamentarium of available modalities for management of non-seasonal depression. Clinicians should be familiar with its application and be able to implement it in recalcitrant sufferers.
The FDA accepts a New Drug Application for novel antidepressant.
This review highlights an important diagnostic and therapeutic task: the importance of differentiating true bipolar disorder/obsessive-compulsive disorder comorbidity from BD with secondary OCD.
Emerging infectious disease outbreaks cause significant fear and uncertainty. Psychiatrists can play an important role in supporting the well-being of patients and families, health care personnel, and the general public.
Although the current generation of antidepressants extends back to the late 1980s, efforts to describe the dose-response relationship for treatment of major depressive disorder continue. More in this research update.
This innovative program at Massachusetts General Hospital addresses postoperative pain while preventing relapse in patients a history of opioid use disorder.
High traditional masculinity (HTM) men are more likely to die by suicide than non-HTM men, but they are less likely to report suicide ideation.
Depression, suicidal ideation, self-harming behaviors, and anxiety, as well as lower reaction time and cognitive decline, were found in patients with celiac disease, according to a recent study
How effective is deep brain stimulation for treatment-resistant depression? Take the quiz.